These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23216091)

  • 21. Finding disease variants in Mendelian disorders by using sequence data: methods and applications.
    Ionita-Laza I; Makarov V; Yoon S; Raby B; Buxbaum J; Nicolae DL; Lin X
    Am J Hum Genet; 2011 Dec; 89(6):701-12. PubMed ID: 22137099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway.
    Khutornenko AA; Roudko VV; Chernyak BV; Vartapetian AB; Chumakov PM; Evstafieva AG
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12828-33. PubMed ID: 20566882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.
    Hail N; Chen P; Kepa JJ; Bushman LR; Shearn C
    Free Radic Biol Med; 2010 Jul; 49(1):109-16. PubMed ID: 20399851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells.
    Mohamad Fairus AK; Choudhary B; Hosahalli S; Kavitha N; Shatrah O
    Biochimie; 2017 Apr; 135():154-163. PubMed ID: 28196676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo.
    Zameitat E; Freymark G; Dietz CD; Löffler M; Bölker M
    Appl Environ Microbiol; 2007 May; 73(10):3371-9. PubMed ID: 17369345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
    Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
    Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of human dihydroorotate dehydrogenase for interaction studies with lipid bilayers.
    Rodriguez JMO; Krupinska E; Wacklin-Knecht H; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1306-1319. PubMed ID: 31997699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe impairment of nucleotide synthesis through inhibition of mitochondrial respiration.
    Gattermann N; Dadak M; Hofhaus G; Wulfert M; Berneburg M; Loeffler ML; Simmonds HA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1275-9. PubMed ID: 15571245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome sequencing identifies the cause of a mendelian disorder.
    Ng SB; Buckingham KJ; Lee C; Bigham AW; Tabor HK; Dent KM; Huff CD; Shannon PT; Jabs EW; Nickerson DA; Shendure J; Bamshad MJ
    Nat Genet; 2010 Jan; 42(1):30-5. PubMed ID: 19915526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain.
    Löffler M; Carrey EA; Knecht W
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1281-1305. PubMed ID: 32043431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
    Klotz L; Eschborn M; Lindner M; Liebmann M; Herold M; Janoschka C; Torres Garrido B; Schulte-Mecklenbeck A; Gross CC; Breuer J; Hundehege P; Posevitz V; Pignolet B; Nebel G; Glander S; Freise N; Austermann J; Wirth T; Campbell GR; Schneider-Hohendorf T; Eveslage M; Brassat D; Schwab N; Loser K; Roth J; Busch KB; Stoll M; Mahad DJ; Meuth SG; Turner T; Bar-Or A; Wiendl H
    Sci Transl Med; 2019 May; 11(490):. PubMed ID: 31043571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exome sequencing makes medical genomics a reality.
    Biesecker LG
    Nat Genet; 2010 Jan; 42(1):13-4. PubMed ID: 20037612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase.
    Rawls J; Knecht W; Diekert K; Lill R; Löffler M
    Eur J Biochem; 2000 Apr; 267(7):2079-87. PubMed ID: 10727948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Craniofacial disorders that have phenotypic overlap with Treacher Collins syndrome.
    Green B; Nikkhah D; Cobb AR; Dunaway DJ
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):e234-5. PubMed ID: 23664577
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitochondrial-Linked
    Peeters MJW; Aehnlich P; Pizzella A; Mølgaard K; Seremet T; Met Ö; Rasmussen LJ; Thor Straten P; Desler C
    Front Immunol; 2021; 12():718863. PubMed ID: 34899685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Dihydroorotate Dehydrogenase Inhibitors Using the Cell Painting Assay.
    Schölermann B; Bonowski J; Grigalunas M; Burhop A; Xie Y; Hoock JGF; Liu J; Dow M; Nelson A; Nowak C; Pahl A; Sievers S; Ziegler S
    Chembiochem; 2022 Nov; 23(22):e202200475. PubMed ID: 36134475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial inhibition of mitochondrial-linked pyrimidine synthesis increases tumorigenic potential and lysosome accumulation.
    Desler C; Durhuus JA; Hansen TL; Anugula S; Zelander NT; Bøggild S; Rasmussen LJ
    Mitochondrion; 2022 May; 64():73-81. PubMed ID: 35346867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mandibulofacial dysostosis, microtia, and limb anomalies in a newborn: a new form of acrofacial dysostosis syndrome?
    Zhang Y; Dai Y; Liu Y; Ren J
    Clin Genet; 2010 Dec; 78(6):570-4. PubMed ID: 20412112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Warburg effect modulates DHODH role in ferroptosis: a review.
    Amos A; Amos A; Wu L; Xia H
    Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.